Tretter Felix, Wolkenhauer Olaf, Meyer-Hermann Michael, Dietrich Johannes W, Green Sara, Marcum James, Weckwerth Wolfram
Bertalanffy Center for the Study of Systems Science, Vienna, Austria.
Department of Systems Biology & Bioinformatics, University of Rostock, Rostock, Germany.
Front Med (Lausanne). 2021 Mar 29;8:640974. doi: 10.3389/fmed.2021.640974. eCollection 2021.
Precision medicine and molecular systems medicine (MSM) are highly utilized and successful approaches to improve understanding, diagnosis, and treatment of many diseases from bench-to-bedside. Especially in the COVID-19 pandemic, molecular techniques and biotechnological innovation have proven to be of utmost importance for rapid developments in disease diagnostics and treatment, including DNA and RNA sequencing technology, treatment with drugs and natural products and vaccine development. The COVID-19 crisis, however, has also demonstrated the need for systemic thinking and transdisciplinarity and the limits of MSM: the neglect of the bio-psycho-social systemic nature of humans and their context as the object of individual therapeutic and population-oriented interventions. COVID-19 illustrates how a medical problem requires a transdisciplinary approach in epidemiology, pathology, internal medicine, public health, environmental medicine, and socio-economic modeling. Regarding the need for conceptual integration of these different kinds of knowledge we suggest the application of general system theory (GST). This approach endorses an organism-centered view on health and disease, which according to Ludwig von Bertalanffy who was the founder of GST, we call Organismal Systems Medicine (OSM). We argue that systems science offers wider applications in the field of pathology and can contribute to an integrative systems medicine by (i) integration of evidence across functional and structural differentially scaled subsystems, (ii) conceptualization of complex multilevel systems, and (iii) suggesting mechanisms and non-linear relationships underlying the observed phenomena. We underline these points with a proposal on multi-level systems pathology including neurophysiology, endocrinology, immune system, genetics, and general metabolism. An integration of these areas is necessary to understand excess mortality rates and polypharmacological treatments. In the pandemic era this multi-level systems pathology is most important to assess potential vaccines, their effectiveness, short-, and long-time adverse effects. We further argue that these conceptual frameworks are not only valid in the COVID-19 era but also important to be integrated in a medicinal curriculum.
精准医学和分子系统医学(MSM)是从实验室到临床,在提高对多种疾病的理解、诊断和治疗方面得到高度应用且颇为成功的方法。特别是在新冠疫情期间,分子技术和生物技术创新已证明在疾病诊断和治疗的快速发展中至关重要,包括DNA和RNA测序技术、药物和天然产物治疗以及疫苗研发。然而,新冠危机也凸显了系统思维和跨学科性的必要性以及分子系统医学的局限性:忽视了人类生物心理社会系统的本质及其作为个体治疗和以人群为导向干预对象的背景。新冠疫情说明了一个医学问题如何需要在流行病学、病理学、内科、公共卫生、环境医学和社会经济建模等方面采用跨学科方法。关于整合这些不同类型知识的概念需求,我们建议应用一般系统理论(GST)。这种方法支持以生物体为中心的健康和疾病观,根据一般系统理论的创始人路德维希·冯·贝塔朗菲的说法,我们将其称为生物体系统医学(OSM)。我们认为系统科学在病理学领域有更广泛的应用,并且可以通过以下方式为整合系统医学做出贡献:(i)整合跨功能和结构不同尺度子系统的证据;(ii)对复杂多层次系统进行概念化;(iii)提出观察到的现象背后的机制和非线性关系。我们通过关于多层次系统病理学的提议来强调这些观点,该病理学包括神经生理学、内分泌学、免疫系统、遗传学和一般代谢。整合这些领域对于理解超额死亡率和多药联合治疗是必要的。在疫情时代,这种多层次系统病理学对于评估潜在疫苗、其有效性、短期和长期不良反应最为重要。我们进一步认为,这些概念框架不仅在新冠疫情时代有效,而且对于整合到医学课程中也很重要。